Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice

Nadir Yalcin; Karel Allegaert

doi:10.1016/j.ymgme.2022.09.003

Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice

Nadir Yalcin
, Karel Allegaert

Division of Clinical Pharmacy

KU Leuven
Erasmus University Rotterdam

Research output: Contribution to journal › Comment/debate

1 Citation (Scopus)

Original language	English
Pages (from-to)	210-212
Number of pages	3
Journal	Molecular Genetics and Metabolism
Volume	137
Issue number	1-2
DOIs	https://doi.org/10.1016/j.ymgme.2022.09.003
Publication status	Published - 1 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Genetic variation
Newborn
Pharmacodynamics
Pharmacogenetics
Pharmacokinetics
Precision medicine
Screening

Access to Document

10.1016/j.ymgme.2022.09.003

Cite this

@article{bed920d8c53741018c9f3a62386dc1ac,

title = "Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice",

keywords = "Genetic variation, Newborn, Pharmacodynamics, Pharmacogenetics, Pharmacokinetics, Precision medicine, Screening",

author = "Nadir Yalcin and Karel Allegaert",

year = "2022",

month = sep,

day = "1",

doi = "10.1016/j.ymgme.2022.09.003",

language = "English",

volume = "137",

pages = "210--212",

journal = "Molecular Genetics and Metabolism",

issn = "1096-7192",

publisher = "Academic Press Inc.",

number = "1-2",

}

TY - JOUR

T1 - Fetal pharmacogenetic screening to improve neonatal pharmacotherapy

T2 - From feasibility to personalized practice

AU - Yalcin, Nadir

AU - Allegaert, Karel

PY - 2022/9/1

Y1 - 2022/9/1

KW - Genetic variation

KW - Newborn

KW - Pharmacodynamics

KW - Pharmacogenetics

KW - Pharmacokinetics

KW - Precision medicine

KW - Screening

UR - https://www.scopus.com/pages/publications/85138166957

U2 - 10.1016/j.ymgme.2022.09.003

DO - 10.1016/j.ymgme.2022.09.003

M3 - Comment/debate

C2 - 36152474

AN - SCOPUS:85138166957

SN - 1096-7192

VL - 137

SP - 210

EP - 212

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

IS - 1-2

ER -

Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice

UN SDGs

Keywords

Access to Document

Other files and links

Cite this